phenyl acetate has been researched along with Eczema, Atopic in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (12.50) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 20 (62.50) | 29.6817 |
| 2010's | 4 (12.50) | 24.3611 |
| 2020's | 3 (9.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, BL; Huang, HY; Huang, YM; Lee, CC; Lin, BF; Lu, C; Shen, YR; Su, NW; Wang, LC | 1 |
| Chang, CI; Chen, PC; Huang, SY; Liu, HL; Lo, YH; Wen, ZH; Yao, ZK | 1 |
| Garland, T; Grindlay, DJC; Harman, KE; Olabi, B; Rogers, NK; Worboys, S | 1 |
| Chin, WK | 1 |
| Mosser-Goldfarb, JL; Yanes, DA | 1 |
| Chin, WK; Lee, SWH | 1 |
| Holme, H; Winckworth, LC | 1 |
| Gerard, A; Harkisoon, S | 1 |
| Fanelli, M; Ferrannini, A; Nettis, E; Pannofino, A; Tursi, A | 1 |
| Stone, KD | 1 |
| Paller, AS; Silverberg, NB | 1 |
| Jackson, CM; Lee, DK; Lipworth, BJ | 1 |
| Fok, TF; Hon, KL; Leung, TF; Ma, KC; Wong, Y | 1 |
| Busch-Sørensen, M; Stausbøl-Grøn, B; Veien, NK | 1 |
| Angelova-Fischer, I; Tsankov, N | 1 |
| Choudhury, AM; Islam, MM; Rahman, ML | 1 |
| Ngamphaiboon, J | 1 |
| Arai, I; Futaki, N; Hashimoto, Y; Honma, Y; Inoue, T; Koizumi, C; Nakaike, S; Nakanishi, Y; Ono, N; Sakurai, T; Sugimoto, M; Takahashi, N; Takaoka, A; Tanami, T; Yagi, M | 1 |
| Dickerson, KS; Luttermoser, GK; Scow, DT | 1 |
| Arai, I; Futaki, N; Hashimoto, Y; Honma, Y; Nakaike, S; Sakurai, T; Sugimoto, M | 1 |
| Barclay, G; Berth-Jones, J; Friedmann, PS; Hotchkiss, K; Ogboli, M; Palmer, R; Tan, E | 1 |
| Bener, A; Ehlayel, MS; Sabbah, A | 1 |
| David-Bajar, K; Yanase, DJ | 1 |
| Chan, HH; Leung, TF; Pei, AY | 1 |
| Wergowske, GL | 1 |
| Kägi, MK | 1 |
| Bjerke, T; Damsgaard, TM; Herlin, T; Nielsen, BW; Schiøtz, PO; Thestrup-Pedersen, K | 1 |
| Binder, R; McCleary, J | 1 |
| McCuistion, CH; Schoch, EP; Warthan, TL | 1 |
| Cotton, DW; Mier, PD; van den Hurk, HH | 1 |
| Butov, IuS; Khmaganova, AV; Somov, BA | 1 |
6 review(s) available for phenyl acetate and Eczema, Atopic
| Article | Year |
|---|---|
What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 2: systemic therapies.
Topics: Acetates; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Therapy; Child; Complementary Therapies; Cyclopropanes; Cyclosporine; Cytochrome P-450 CYP1A2 Inducers; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive Agents; Janus Kinase Inhibitors; Naltrexone; Narcotic Antagonists; Omalizumab; Placebo Effect; Probiotics; Quinolines; Sulfides; Ustekinumab; Vitamin D | 2020 |
Emerging therapies for atopic dermatitis: The prostaglandin/leukotriene pathway.
Topics: Acetates; Adult; Animals; Cyclopropanes; Dermatitis, Atopic; Female; Forecasting; Humans; Hydroxyurea; Leukotriene Antagonists; Male; Molecular Targeted Therapy; Prostaglandin Antagonists; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome | 2018 |
A systematic review on the off-label use of montelukast in atopic dermatitis treatment.
Topics: Acetates; Cyclopropanes; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Off-Label Use; Quinolines; Randomized Controlled Trials as Topic; Sulfides | 2018 |
Atopic diseases of childhood.
Topics: Acetates; Adrenergic beta-Agonists; Animals; Asthma; Child; Cyclopropanes; Dermatitis, Atopic; Environmental Exposure; Feces; Genetic Predisposition to Disease; Hepatitis A Virus Cellular Receptor 1; Hepatitis A Virus Cellular Receptor 2; Humans; Hypersensitivity, Immediate; Immunosuppressive Agents; Leukotriene Antagonists; Membrane Proteins; Mice; Quinolines; Receptors, Virus; Skin; Sulfides; T-Lymphocytes; Tacrolimus | 2003 |
Leukotriene inhibitors in the treatment of allergy and asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Cyclopropanes; Dermatitis, Atopic; Humans; Hydroxyurea; Hypersensitivity; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Sulfonamides; Tosyl Compounds | 2007 |
Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?
Topics: Acetates; Cyclopropanes; Dermatitis, Atopic; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Sulfides; Urticaria | 2001 |
11 trial(s) available for phenyl acetate and Eczema, Atopic
| Article | Year |
|---|---|
Efficacy and tolerability of montelukast as a therapeutic agent for severe atopic dermatitis in adults.
Topics: Acetates; Adolescent; Adult; Cyclopropanes; Dermatitis, Atopic; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2002 |
The effects of butterbur on the histamine and allergen cutaneous response.
Topics: Acetates; Adult; Anti-Inflammatory Agents; Cross-Over Studies; Cyclopropanes; Dermatitis, Atopic; Double-Blind Method; Female; Histamine; Humans; Male; Petasites; Phytotherapy; Quinolines; Skin Tests; Sulfides; Terfenadine | 2004 |
Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis.
Topics: Acetates; Administration, Oral; Adolescent; Child; Child, Preschool; Cyclopropanes; Dermatitis, Atopic; Female; Humans; Leukotriene Antagonists; Lipopolysaccharide Receptors; Male; Quinolines; Statistics, Nonparametric; Sulfides; Treatment Outcome | 2005 |
Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
Topics: Acetates; Adolescent; Adult; Age Factors; Aged; Cyclopropanes; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Prospective Studies; Quinolines; Severity of Illness Index; Sulfides | 2005 |
Effectiveness of montelukast in the treatment of atopic dermatitis.
Topics: Acetates; Adolescent; Adult; Cyclopropanes; Dermatitis, Atopic; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides; Treatment Outcome | 2006 |
A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Topics: Acetates; Adolescent; Adult; Cyclopropanes; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Placebos; Quinolines; Sulfides; Treatment Outcome | 2007 |
Montelukast treatment in children with moderately severe atopic dermatitis.
Topics: Acetates; Administration, Oral; Adolescent; Blood Cell Count; Child; Child, Preschool; Cyclopropanes; Dermatitis, Atopic; Drug Administration Schedule; Eosinophils; Female; Histamine H1 Antagonists; Humans; Immunoglobulin E; Male; Quinolines; Sleep; Sulfides; Treatment Outcome | 2007 |
The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
Topics: Acetates; Adolescent; Adult; Cyclopropanes; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Pilot Projects; Quinolines; Sulfides; Treatment Outcome | 2001 |
Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study.
Topics: Acetates; Activities of Daily Living; Administration, Oral; Adolescent; Child; Cyclopropanes; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Pilot Projects; Quinolines; Sulfides | 2001 |
Comparison of fluocinonide in a double-blind study with betamethasone valerate.
Topics: Acetates; Betamethasone; Dermatitis, Atopic; Dermatitis, Seborrheic; Drug Compounding; Eczema; Fluocinolone Acetonide; Humans; Ointments; Psoriasis; Time Factors; Valerates | 1972 |
A double-blind comparison of fluocinonide and betamethasone valerate ointments.
Topics: Acetates; Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Dermatitis, Atopic; Dermatitis, Contact; Eczema; Fluocinolone Acetonide; Humans; Lichen Planus; Ointments; Psoriasis; Valerates | 1973 |
15 other study(ies) available for phenyl acetate and Eczema, Atopic
| Article | Year |
|---|---|
Lower caprylate and acetate levels in the breast milk is associated with atopic dermatitis in infancy.
Topics: Acetates; Breast Feeding; Caprylates; Dermatitis, Atopic; Female; Humans; Infant; Milk, Human | 2022 |
The anti-inflammatory properties of ethyl acetate fraction in ethanol extract from Sarcodia suiae sp. alleviates atopic dermatitis-like lesion in mice.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Cytokines; Dermatitis, Atopic; Dinitrochlorobenzene; Ethanol; Inflammation; Mice; Mice, Inbred BALB C; Plant Extracts; Rhodophyta; Skin | 2022 |
Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all.
Topics: Acetates; Cyclopropanes; Dermatitis, Atopic; Humans; Leukotriene Antagonists; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Treatment Outcome | 2018 |
Montelukast can reduce the severity and extent of atopic dermatitis.
Topics: Acetates; Asthma; Child; Clinical Trials as Topic; Cyclopropanes; Dermatitis, Atopic; Humans; Information Storage and Retrieval; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2013 |
Singulair-induced anaphylaxis?
Topics: Acetates; Anaphylaxis; Anti-Asthmatic Agents; Asthma; Child, Preschool; Conjunctivitis, Allergic; Cyclopropanes; Dermatitis, Atopic; Humans; Infant; Leukotriene Antagonists; Male; Prognosis; Quinolines; Respiratory Hypersensitivity; Sulfides | 2009 |
[Leukotriene antagonist. All around talent in asthma and allergies].
Topics: Acetates; Asthma; Cyclopropanes; Dermatitis, Atopic; Humans; Leukotriene Antagonists; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Treatment Outcome | 2002 |
Leukotriene receptor antagonists are ineffective for severe atopic dermatitis.
Topics: Acetates; Adolescent; Adult; Aged; Child; Child, Preschool; Cyclopropanes; Dermatitis, Atopic; Female; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2004 |
Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
Topics: Acetates; Adult; Cyclopropanes; Dermatitis, Atopic; Female; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2005 |
Montelukast in general pediatric practices.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Dermatitis, Atopic; Family Practice; Humans; Leukotriene Antagonists; Pediatrics; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides | 2005 |
Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Topics: Acetates; Animals; Antipruritics; Concanavalin A; Cyclohexanes; Cytokines; Dermatitis, Atopic; Dexamethasone; Humans; Hydantoins; Immunosuppressive Agents; Inflammation; Male; Mice; Platelet Aggregation; Prostaglandin D2; Pruritus; Receptors, Immunologic; Receptors, Prostaglandin; Skin; Sulfhydryl Compounds; Tacrolimus; Wound Healing | 2007 |
The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Antipruritics; Arachidonic Acid; Cyclohexanes; Dermatitis, Atopic; Dexamethasone; Gene Expression Regulation; Male; Mice; Prostaglandin D2; Pruritus; Receptors, Prostaglandin; Skin; Sulfhydryl Compounds; Water Loss, Insensible | 2007 |
Treatment-resistant atopic dermatitis.
Topics: Acetates; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antipruritics; Cyclopropanes; Dermatitis, Atopic; Diabetes Complications; Female; Humans; Hydroxyzine; Leukotriene Antagonists; Prednisone; Quinolines; Sulfides; Treatment Failure | 2001 |
Hyperosmolarity selectively enhances IgE-receptor-mediated histamine release from human basophils.
Topics: Acetates; Alkanesulfonates; Alkanesulfonic Acids; Antigens, Differentiation, B-Lymphocyte; Basophils; Buffers; Dermatitis, Atopic; Fetal Blood; Histamine Release; Humans; Immunoglobulin E; Osmolar Concentration; Piperazines; Receptors, Fc; Receptors, IgE; Reference Values; Reproducibility of Results | 1992 |
Hydrolysis of -naphthyl acetate by plasma and by skin extracts from normal and atopic subjects.
Topics: Acetates; Acetylcholinesterase; Biopsy; Dermatitis, Atopic; Fluorescence; Humans; Hydrolysis; In Vitro Techniques; Kinetics; Naphthalenes; Plasma; Skin | 1973 |
[Experience in the use of 0.1 percent fluperolone ointment methral in various allergic dermatoses].
Topics: Acetates; Dermatitis, Atopic; Dermatitis, Contact; Fluprednisolone; Ointments | 1970 |